LORAINE IPPOLITO: Open Payments
NPI 1194782425 · ORCHARD PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,859 in 91 payments from 21 companies in 2025. Trend: 2023 $1,492 · 2024 $1,794 · 2025 $1,859
Food & beverage: $1,859
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $396 |
| Novo Nordisk Inc | 15 | $241 |
| Lilly USA, LLC | 9 | $178 |
| Exact Sciences Corporation | 7 | $174 |
| GlaxoSmithKline, LLC. | 8 | $153 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $104 |
| Amgen Inc. | 5 | $81 |
| PFIZER INC. | 3 | $61 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $56 |
Products named: AIRSUPRA, Cologuard Collection Kit, MOUNJARO, TRELEGY ELLIPTA, XIFAXAN, REXULTI, FARXIGA, OTEZLA.
Industry payments across NY — which companies pay providers there.
